Previous studies indicate that
adenosine supplementation or
nitric oxide synthase (NOS) inhibition during reperfusion exert protective effects against
myocardial ischemia-reperfusion (I/R) injury. We wanted to test the hypothesis that NOS inhibition before I/R also protects the myocardium against further injury and aimed to determine the involvement of
adenosine receptors in a perfused rat heart model. Rats were injected with 10 mg/kg of
L-NAME (
N(omega)-nitro-L-arginine methyl ester) or
L-NAME + SPT (8-(p-sulfophenyl)-theophylline)--an
adenosine antagonist - at 2 x 25 mg/kg or with a saline
buffer, 24 hrs prior to heart excision. The hearts, perfused retrogradely were subjected to 60 min of global
ischemia followed by 120 min reperfusion.
L-NAME decreased NOx (
nitrite and
nitrate) production (16.2 +/- 3.2 vs. 7.0 +/- 1.8 micromol/L; P<0.05) in vivo and increased the release of
troponin I (0.04 +/- 0.01 vs. 0.02 +/- 0.01 microg/L; P<0.05) in the plasma, compared to controls. After 120 min of reperfusion, there was a higher release of
adenosine (26.1 +/- 2.2 vs. 2.4 +/- 1.2 nmol/min; P<0.01) and a decrease in
troponin I levels (0.19 +/-0.07 vs. 0.59 +/- 0.16 ng/min; P<0.05) in the
L-NAME group compared to controls. These results were accompanied by a higher proportion of recovery of left ventricular developed pressure (72.0 +/- 4.0 vs. 60.0 +/- 4.0%; P<0.05) and coronary flow (72.0 +/- 5.0 vs. 51.0 +/- 4.0%; P<0.05) in the
L-NAME group. These beneficial effects were not blocked by the
adenosine receptor antagonist. The present study reveals that
L-NAME protects against I/R injury when the inhibitor is administered 24 hrs before
ischemia. The beneficial effects observed in this model appear to be independent of
adenosine receptor stimulation.